title: [Value of coagulation function and fibrinolytic system assessment in patients with gestational diabetes mellitus].
abstract: OBJECTIVE
  To study the clinical implications of changes of coagulation function and fibrinolytic system in patients with gestational diabetes mellitus (GDM).
  
  
  METHODS
  Twenty non-pregnant women, 20 with normal pregnancy and 46 with GDM were enrolled in this study for examinations of platelet alpha-granule membrane protein (GMP-140), Von Willebrand factor (vWF), antithrombin III activity (AT-III), plasminogen activity (PLG), activity of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI).
  
  
  RESULTS
  vWF, GMP-140, PLG, D-dimer, PAI were obviously elevated while t-PA was lower in GDM patients as compared with the measurement in non-pregnant women and women with normal pregnancy (P<0.01). AT-III and ProC measurement showed no significant differences between GDM patients and women of the other two groups.
  
  
  CONCLUSIONS
  GDM patients may have elevated platelet activation and fibrinolyic activity as well as vascular endothelial injuries, and antenatal assessment of the coagulation function can be of value for prevention and treatment of GDM.
authors.affiliation: Department of Obstetrics and Gynecology, Guangzhou Chest Hospital, Guangzhou 510095, China. liubaoying169@sina.com
authors.forename: Bao-Ying
authors.initials: BY
authors.lastname: Liu
authors.forename: Yi-Lan
authors.initials: YL
authors.lastname: Jian
authors.forename: Mei
authors.initials: M
authors.lastname: Zhong
authors.forename: Yan-Hong
authors.initials: YH
authors.lastname: Yu
authors.forename: Qian
authors.initials: Q
authors.lastname: Wang
authors.forename: Jun
authors.initials: J
authors.lastname: Zhang
mesh_terms: D000328:Adult; D001777:Blood Coagulation / Q000502:physiology*; D016640:Diabetes, Gestational / Q000097:blood* / Q000503:physiopathology; D004730:Endothelium, Vascular / Q000503:physiopathology; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005342:Fibrinolysis / Q000502:physiology*; D006801:Humans; D019007:P-Selectin / Q000097:blood; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood; D015539:Platelet Activation / Q000502:physiology; D011247:Pregnancy; D011263:Pregnancy Trimester, Third / Q000097:blood; D010959:Tissue Plasminogen Activator / Q000097:blood; D014841:von Willebrand Factor / Q000032:analysis
chemical_list: D005338:Fibrin Fibrinogen Degradation Products; D019007:P-Selectin; D017395:Plasminogen Activator Inhibitor 1; C036309:fibrin fragment D; D014841:von Willebrand Factor; D010959:Tissue Plasminogen Activator